PTX Stock UPDATES Pernix Therapeutics Holdings Inc. (PTX) 7.34

New Post Public Reply Private Reply Replies (0) Message Board

Sep 12, 2014 at 10:56 AM

Pernix Therapeutics Holdings Inc. (PTX) 7.34 $PTX

Pernix Therapeutics Closes Acquisition of Treximet. Raises $220m Senior Notes. Issues Updated 2014 Guidance.
Business Wire - Wed Aug 20, 7:01AM CDT
Pernix Therapeutics Holdings, Inc. (NASDAQ GM: PTX) ("Pernix" or the "Company"

, a specialty pharmaceutical company, announced today that it has closed its acquisition of Treximet(R) (sumatriptan / naproxen sodium) for the acute treatment of migraine attacks with or without aura in adults. Pernix first announced its agreement with GlaxoSmithKline (NYSE: GSK) to acquire the U.S rights to Treximet(R) on May 14. Pernix's expanded team of approximately 100 specialty sales professionals will support the sales and marketing of Treximet(R). The Company will hold a conference call on Wednesday, August 20 at 9:00 a.m. EDT to discuss this acquisition.

POZEN Announces U.S. Rights For TREXIMET(R) Have Been Acquired by Pernix Therapeutics
Business Wire - Wed Aug 20, 7:00AM CDT
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced that the acquisition of all of GlaxoSmithKline's (GSK) rights to Treximet(R) (sumatriptan / naproxen sodium) have been acquired by Pernix Therapeutics Holdings, Inc. (Pernix). The previously announced transaction was contingent upon Pernix securing financing, which is now complete. As part of the divestiture, GSK has assigned the Product Development and Commercialization Agreement between POZEN and GSK to Pernix, and POZEN and Pernix have amended the agreement to address rights of the parties and future development.

Pernix Therapeutics Reports Second Quarter 2014 Financial Results
Business Wire - Mon Aug 11, 7:30AM CDT
Pernix Therapeutics Holdings, Inc. ("Pernix" or the "Company"

(NASDAQ: PTX), a specialty pharmaceutical company, today announced financial results for the quarter and year-to-date periods ended June 30, 2014.

Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed
PR Newswire - Thu Aug 07, 8:20AM CDT
On Wednesday, August 6, 2014, the NASDAQ Composite ended at 4,355.05, up 0.05%, the Dow Jones Industrial Average advanced 0.08%, to finish the day at 16,443.34, and the S&P 500 closed the day flat at 1,920.24. The losses were broad based as six out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 700.41, down 0.12%, while the index has advanced 5.09% in the previous three months. Investor-Edge has initiated coverage on the following equities: Theravance Inc. (NASDAQ: THRX), Akorn Inc. (NASDAQ: AKRX), Endo International PLC (NASDAQ: ENDP), Pernix Therapeutics Holdings Inc. (NASDAQ: PTX), and Depomed Inc. (NASDAQ: DEPO). Free research on these five companies can be accessed at:

Closing for Pernix Transaction to Acquire Treximet(R) Tablets for Migraine from GSK Delayed
Business Wire - Mon Aug 04, 8:15AM CDT
Pernix Therapeutics Holdings, Inc. (NASDAQ GM: PTX) ("Pernix" or the "Company"

, a specialty pharmaceutical company, today announced that the closing of its transaction to acquire the U.S. rights to Treximet(R) (sumatriptan / naproxen sodium) for the acute treatment of migraine attacks with or without aura in adults has been delayed due to a short-term supply constraint for the product. The Company is working with GlaxoSmithKline to ensure sufficient supply to meet anticipated demand. The Company and its lenders are also performing additional due diligence related to this supply issue.

Nasdaq stocks posting largest percentage decreases
AP - Tue Jul 29, 12:30PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

Pernix Therapeutics to Report Second Quarter 2014 Financial Results on August 11, 2014
Business Wire - Fri Jul 25, 8:00AM CDT
Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced that it will release its second quarter 2014 financial results before the U.S. stock market opens on Monday, August 11, 2014 and has scheduled a conference call at 10:00 a.m. EDT that day to discuss the financial results.

Gyrotron Technology Inc. Elects Jan H. Loeb to Its Board of Directors
Marketwire - Tue Jul 22, 2:11PM CDT
Gyrotron Technology Inc. (PINKSHEETS: GYTI), a developer of innovative industrial technologies, announced today that Mr. Jan H. Loeb has been elected to its Board of Directors.

Commit To Purchase Pernix Therapeutics Holdings At $7.50, Earn 23.9% Annualized Using Options
StockOptionsChannel.com - Fri Jul 11, 11:21AM CDT
Investors considering a purchase of Pernix Therapeutics Holdings, Inc. stock, but cautious about paying the going market price of $8.77/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Pernix Therapeutics hires Sanjay Patel as CFO
M2 - Tue Jun 24, 6:33AM CDT
Pharmaceutical company Pernix Therapeutics Holdings (NASDAQ MKT

TX) disclosed on Monday that it has appointed Sanjay Patel as its chief financial officer.

Pernix Therapeutics Appoints Chief Financial Officer
Business Wire - Mon Jun 23, 10:38AM CDT
Pernix Therapeutics Holdings, Inc. ("Pernix" or the "Company"

(NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced the appointment of Sanjay Patel as Chief Financial Officer.

Agreements, Orphan Drug Designations, and Management Changes - Analyst Notes on Medtronic, DARA BioSciences, Sequenom, AcelRx and Pernix
PR Newswire - Thu Jun 19, 4:20AM CDT
Today, Analysts Review released its analysts' notes regarding Medtronic, Inc. (NYSE: MDT), DARA BioSciences, Inc (NASDAQ: DARA), Sequenom Inc. (NASDAQ: SQNM), AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) and Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3874-100free.

Pharmaceuticals Stocks Technical Momentum -- Research on Jazz Pharma, Omeros, Pernix Therapeutics Holdings, and Salix Pharma
PR Newswire - Mon Jun 16, 6:10AM CDT
On Friday, June 13, 2014, the NASDAQ Composite ended at 4,310.65, up 0.30%, the Dow Jones Industrial Average finished the day 0.25% higher at 16,775.74, and the S&P 500 closed at 1,936.16, up 0.31%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 688.44, down 0.02%, while the index has advanced 2.46% in the last one month. Investor-Edge has initiated coverage on the following equities: Jazz Pharmaceuticals PLC (NASDAQ: JAZZ), Omeros Corp. (NASDAQ: OMER), Pernix Therapeutics Holdings Inc. (NASDAQ: PTX) and Salix Pharmaceuticals Ltd (NASDAQ: SLXP). Free technical research on JAZZ, OMER, PTX and SLXP can be downloaded upon signing up at:

Pernix Therapeutics to Present at the 13th Annual Needham Healthcare Conference
Business Wire - Wed Apr 02, 8:34AM CDT
Pernix Therapeutics Holdings, Inc. ("Pernix" or the "Company"

(NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that Pernix CEO Doug Drysdale is scheduled to present at the 13th Annual Needham Healthcare Conference in New York City on Wednesday, April 9, 2014, at 12:50 p.m. ET. The Needham Healthcare Conference is considered to be one of the best venues for leading life science and medical technology companies, and the institutions who invest in the sector.

Pernix expects USD6.2m in net proceeds and annual cost savings from Pernix Manufacturing LLC's sale
M2 - Wed Apr 02, 5:28AM CDT
Pharmaceutical company Pernix Therapeutics Holdings (NASDAQ MKT

TX) said on Tuesday that it has entered into a definitive agreement to sell its Houston, TX-based manufacturing operations, Pernix Manufacturing LLC (PML).

Pernix Agrees to Divest Manufacturing Facility
Business Wire - Tue Apr 01, 7:30AM CDT
Pernix Therapeutics Holdings, Inc. ("Pernix" or the "Company"

(NASDAQ MKT

TX), a specialty pharmaceutical company, today announced that it has signed a definitive agreement to divest its Houston, TX-based manufacturing operations, Pernix Manufacturing, LLC ("PML"

to Woodfield Pharmaceutical LLC ("Woodfield"

.

Health Care Stocks on our Radar -- Research on Novo Nordisk, Tianyin Pharma, Pernix Therapeutics Holdings, and Oculus Innovative Sciences
PR Newswire - Wed Mar 26, 12:10PM CDT
On Tuesday, March 25, 2014, the NASDAQ Composite finished at 4,234.27, up 0.19%. The Dow Jones Industrial Average closed the session at 16,367.88, up 0.56% and the S&P 500 ended the day at 1,865.62, higher by 0.44%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index finished the day at 671.69, up 0.83%, and the same has gained 5.27% in the previous three months. Investor-Edge has initiated coverage on the following equities: Novo Nordisk A/S (NYSE: NVO), Tianyin Pharmaceutical Co. Inc. (NYSE MKT: TPI), Pernix Therapeutics Holdings (NASDAQ: PTX) and Oculus Innovative Sciences Inc. (NASDAQ: OCLS). Free technical research on NVO, TPI, PTX and OCLS can be downloaded upon signing up at:

Commit To Purchase Pernix Therapeutics Holdings At $5, Earn 24.1% Annualized Using Options
StockOptionsChannel.com - Tue Mar 25, 11:19AM CDT
Investors considering a purchase of Pernix Therapeutics Holdings, Inc. stock, but cautious about paying the going market price of $5.66/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Pernix Therapeutics Appoints Senior Vice President of Sales and Marketing
Business Wire - Tue Mar 18, 9:35AM CDT
Pernix Therapeutics Holdings, Inc. ("Pernix" or the "Company"

(NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced the appointment of Rick Shalaby as Senior Vice President of Sales and Marketing effective March 17, 2014.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ADI Global Faces Investor Investigation Over Major Write-Down

Towering Goodwill Falls and Investor Scrutiny Well, let's dig into this mess ADI Global Distribution has found itself in. If you were hanging onto ADIG shares, your portfolio probably took quite the hit when they revealed a nasty $659 million goodwill write-down. Imagine opening up those financials and seeing about 62% of goodwill value wiped out overnight. Suddenly, that...

Optikos Secures CMMC Level 2, Eyeing Defense Market

Optikos Levels Up with CMMC Certification In a world where cybersecurity threats are lurking around every corner, Optikos has just joined the rarefied ranks of the top 1% of U.S. defense suppliers by grabbing the CMMC Level 2 certification. Let me tell you, this isn't just some shiny badge for show; it's a gateway to big defense contracts. Crunching the Numbers Of the...

Terra Kaffe's Big Win with Oprah's Endorsement

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Perennial Housing Group's Big Move into Affordable Housing

Perennial's Ambitious Entry into the Affordable Housing Scene They say the real estate game's all about location, but when you’re diving into affordable housing, it's about necessity too. Perennial Housing Group, under the helm of seasoned CEO Gregory B. Jones, is kicking things off with a hefty acquisition—31 affordable housing communities spread across the Southeast...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

CR&R Workers Join Teamsters, Fight for Fair Conditions

Waste Workers Push Back Against Corporate Pressure The Southern California sun isn't the only thing heating up these days; the waste workers at CR&R Environmental Services have cranked up the heat by voting to join Teamsters Local 396. It's like Groundhog Day in the world of labor rights—same story, different locale, workers banding together for a fair shot. A Stand...

Perpetua Reports Q3 2026 Results, Progress on Project

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Class Action Greenlighted Against Concordia for Title IX Violations

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Samuel Oschin Center Opens, Promising Wonder

By Evelyn Baker Updated Nov 13, 2026 Category News Views 179

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...